IO Biotech @IOBiotech

@IOBiotech is pleased to announce that Mai-Britt Zocca, PhD, President & CEO, will serve on the ‘Keeping Hope Alive: Learnings on How Pre-POC Oncology Biotechs Can Successfully Navigate Current Challenging Times’ virtual panel as part of Lumanity’s Cancer Progress Webinar taking…

@IOBiotech is pleased to announce that we are participating in this year’s Fierce Pharma Week taking place September 8-11 at the Pennsylvania Convention Center. Be sure to stop by and hear insights from Jolie Schafer, PhD, our National Director of Melanoma Medical Science…

@IOBiotech is pleased to announce that members of its senior management team will be attending the following investor conferences in September: Morgan Stanley 23rd Annual Global Healthcare Conference Date: September 9, 2025, fireside chat at 7:45 AM ET Presenters: Mai-Britt…

@IOBiotech today reported financial results for the second quarter ended June 30, 2025. Read more: https: bit.ly/47rSvv6 #IOBiotech #cancervaccines #financialresults

Summer is the time of year when people spend more time outdoors and this Summer Sun Safety Month, @IOBiotech encourages everyone to be proactive about your skin health during the summertime and all year long. Remember to take precautions to reduce the risk of getting skin…

@IOBiotech is a proud sponsor of I.N.N.O.V.A.T.E: INTERNATIONAL NEOADJUVANT IMMUNOTHERAPY ACROSS CANCERS being hosted by BPSOLUTION on July 11th – 12th 2025 in Naples, Italy. This global meeting brings together leaders in the neoadjuvant immunotherapy clinical and translational…

July is UV Safety Month. Ultraviolet radiation is the root cause of most skin cancers and during the month of July, we want to remind you of the importance of sun safety during the summer months when UV exposure is at its peak. Learn three simple steps to practice sun safety and…

During Melanoma and Skin Cancer Awareness Month, our @IOBiotech colleagues across the globe helped spread awareness for melanoma by participating in our ‘Team IO Biotech Step Up for Melanoma Challenge’. Both in teams and individually, and wearing their UPF50 shirts, our…

keyboard_arrow_left Previous keyboard_arrow_right Next

Team members of @IOBiotech were proud to attend Fast Company’s Most Innovative Companies Gala in New York City last week to accept our award for being named to Fast Company’s list of Most Innovative Companies for 2025. Accepting this prestigious award on behalf of all of our…

June is National Cancer Survivors Month, a time to celebrate the strength of cancer survivors and raise awareness for research and support. Learn more about the work being done to improve the lives of all survivors and their caregivers: cancercontrol.cancer.gov/ocs/about/surv…

Our team is proud to have been named to Fast Companies Most Innovative Companies 2025 list! Hear more about what this honor means to @IOBiotech from our President & CEO.

We are excited to be connecting with oncology professionals from around the world at the 2025 ASCO® Annual Meeting! Make sure to stop by our Booth #36165 today to meet our team and learn more about our investigational, immune-modulatory, off-the-shelf therapeutic cancer vaccines…

@IOBiotech is proud to support the Conquer Cancer – Women Who Conquer Cancer and Young Investigator Awards, along with a charity event aiming to raise $10,000 for critical research and patient programs. Be sure to stop by Booth #36165 to participate in our charity event. For…

Make sure to stop by our Booth #36165 at the 2025 ASCO® Annual Meeting! Grab a cup of coffee and check out the videos to learn more about our novel T-win platform and @IOBiotech being named to Fast Companies Most Innovative Companies 2025 list. We also invite you to help us raise…

June 1st is National Cancer Survivors Day®. National Cancer Survivors Day is a Celebration of Life, but it is also a call to action for further research, more resources, and increased public awareness to improve cancer survivors’ quality of life. Join us at the 2025 ASCO®…

Our @IOBiotech team is proud to be developing investigational, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on our T-win® platform that could potentially change the oncology treatment paradigm. The T-win platform is based on a novel approach to cancer…

We are excited to be joining the oncology community at #ASCO25. If you are at the meeting, stop by our Booth #36165 to meet our team, learn more about our novel, investigational, off-the-shelf therapeutic cancer vaccines, and help us raise up to $10,000 to Conquer Cancer, the…

Are you attending the 2025 ASCO® Annual Meeting? Be sure to stop by our Booth #36165 to learn more about our plans to potentially change the oncology treatment paradigm with our investigational, immune-modulatory, off-the-shelf therapeutic cancer vaccines. At the same time, you…

Our team is excited to be attending the 2025 ASCO® Annual Meeting and connecting with oncology professionals from around the world. Reach out to meet with a member of our team at [email protected] We hope to see you there!

@IOBiotech is pleased to announce that members of its management team will be attending the following upcoming investor conferences: TD Cowen 6th Annual Oncology Summit: Insights for ASCO & EHA Virtual Fireside Chat Date: Tuesday, May 27, 2025, 10:30 AM EST Participants:…